BCM
MDCO

Beryl Capital Management’s Medicines Co MDCO Stock Holding History

Beryl Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-711,667
Closed -$60.4M – 65
2019
Q4 		$60.4M Buy
+711,667
New +$47.5M 9.74% 4

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Beryl Capital Management's MDCO Position: Q1 2020 in Review

Beryl Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 711,667 shares — an estimated $60.4M sold.

Beryl Capital Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $60.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Beryl Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Beryl Capital Management sold 711,667 Medicines Co shares in Q1 2020, an estimated $60.4M.
  • Beryl Capital Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • Beryl Capital Management's Medicines Co position peaked at $60.4M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Beryl Capital Management's 13F filing for Q1 2020, filed 15 May 2020.